Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 

Go back to Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 
(NASDAQ: CRBP) Delayed: 8.31 +0.05 (0.61%)
Previous Close $8.26    52 Week High $10.78 
Open $8.28    52 Week Low $1.01 
Day High $8.62    P/E N/A 
Day Low $8.26    EPS $0.00 
Volume 296,068